TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s disease
Open Access
- 3 June 2005
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (6) , 523-528
Abstract
Background: The cytokines tumour necrosis factor (TNF)α and interleukin (IL)10 have been implicated in the pathogenesis of Crohn’s disease (CD), with increased concentrations reported in patients with active disease. However, limited data exist on their effects on disease phenotype in the same population. Certain single nucleotide polymorphisms (SNPs) within the promoter region of the IL10 (-1082G/A, -592C/A) and TNFα (-308G/A, -857C/T) genes have been associated with altered levels of circulating IL10 and TNFα. Methods: We conducted an Australian based case–control study (304 CD patients; 231 healthy controls) of these four SNPs. Further investigation of two SNPs was conducted using a logistic regression analysis. Results: We identified a possible association of both IL10 SNPs and TNFα-857 with CD. Further investigation of a relationship with disease severity showed a significant association of higher producing IL10-1082G and TNFα-857C alleles with stricturing behaviour, which was strongest when these alleles were combined and persisted after multivariate analysis (p = 0.007; odds ratio (OR) 2.37, 95% CI 1.26 to 4.43). In addition, the TNFα-857CC genotype was independently associated with familial CD (p = 0.03; OR 3.12; 95% CI 1.15 to 8.46). Conclusion: These two SNPs may help to predict disease behaviour in CD patients, which may be clinically useful in shaping treatment of the disease at an earlier stage.Keywords
This publication has 30 references indexed in Scilit:
- The complex role of interleukin-10 in autoimmunityJournal of Autoimmunity, 2003
- Mouse models for the study of Crohn's diseaseTrends in Molecular Medicine, 2003
- Decreased Lamina Propria Effector Cell Responsiveness to Interleukin-10 in Ileal Crohn's DiseaseClinical Immunology, 2002
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseNature, 2001
- TheIL-10 gene is not involved in the predisposition to inflammatory bowel diseaseElectrophoresis, 2000
- Interleukin‐10 (IL‐10) genotypes in inflammatory bowel diseaseTissue Antigens, 1999
- Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfaHepatology, 1999
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammationThe Lancet, 1992